Taysha Gene Therapies Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.56

+0.22 (+3.47%)

As of Aug 9, 10:10 PM ET ·

Next Earnings Report

Aug 11, 2026

After Market Close

0 days away

EPS Estimate $-0.12

Revenue Est $630.5K

Earnings Summary

Beats (Last 1) 1/1

Avg Surprise +18.5%

Consecutive Beats 1 quarter

Latest EPS $-0.08

History 1 quarter

Earnings History

Date	Quarter	EPS Est	EPS Actual	Surprise	Surprise %	Result
May 20, 2026	Q2 FY2026	$-0.10	—	—	—	—
Mar 19, 2026	Q1 FY2026	$-0.10	$-0.08	+$0.02	+18.5%	Beat
Mar 4, 2026	Q1 FY2026	$-0.10	—	—	—	—